Parisa Monfared

598 total citations
16 papers, 444 citations indexed

About

Parisa Monfared is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Parisa Monfared has authored 16 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Parisa Monfared's work include Glioma Diagnosis and Treatment (6 papers), Virus-based gene therapy research (3 papers) and Medical Imaging Techniques and Applications (3 papers). Parisa Monfared is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Virus-based gene therapy research (3 papers) and Medical Imaging Techniques and Applications (3 papers). Parisa Monfared collaborates with scholars based in Germany, France and Norway. Parisa Monfared's co-authors include Alexandra Winkeler, Andreas H. Jacobs, Thomas Viel, Yannic Waerzeggers, Mathias Hoehn, Andreas H. Jacobs, Markus Klein, Jürgen Voges, Bernd Neumaier and Roman K. Thomas and has published in prestigious journals such as PLoS ONE, Cancer Research and Science Translational Medicine.

In The Last Decade

Parisa Monfared

16 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parisa Monfared Germany 11 230 99 94 89 62 16 444
R A Kroll United States 8 176 0.8× 86 0.9× 33 0.4× 95 1.1× 101 1.6× 8 474
Heather M. Ames United States 16 411 1.8× 155 1.6× 38 0.4× 126 1.4× 51 0.8× 27 811
Céléna Dubuc Canada 12 151 0.7× 94 0.9× 41 0.4× 53 0.6× 33 0.5× 13 329
Anirudh Sattiraju United States 11 162 0.7× 97 1.0× 74 0.8× 111 1.2× 11 0.2× 24 460
Harry Bulstrode United Kingdom 11 310 1.3× 109 1.1× 20 0.2× 84 0.9× 51 0.8× 29 544
Terence Burns United States 6 192 0.8× 307 3.1× 99 1.1× 134 1.5× 21 0.3× 9 668
George Thom United Kingdom 15 462 2.0× 24 0.2× 189 2.0× 81 0.9× 31 0.5× 22 722
Ilya Gubskiy Russia 10 162 0.7× 110 1.1× 44 0.5× 37 0.4× 14 0.2× 35 451
Michael R. Huff United States 5 234 1.0× 92 0.9× 30 0.3× 60 0.7× 58 0.9× 10 440
Alex M. Spence United States 9 105 0.5× 121 1.2× 126 1.3× 60 0.7× 59 1.0× 16 400

Countries citing papers authored by Parisa Monfared

Since Specialization
Citations

This map shows the geographic impact of Parisa Monfared's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parisa Monfared with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parisa Monfared more than expected).

Fields of papers citing papers by Parisa Monfared

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parisa Monfared. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parisa Monfared. The network helps show where Parisa Monfared may publish in the future.

Co-authorship network of co-authors of Parisa Monfared

This figure shows the co-authorship network connecting the top 25 collaborators of Parisa Monfared. A scholar is included among the top collaborators of Parisa Monfared based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parisa Monfared. Parisa Monfared is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Viel, Thomas, Parisa Monfared, Sonja Schelhaas, et al.. (2013). Optimizing Glioblastoma Temozolomide Chemotherapy Employing Lentiviral-based Anti-MGMT shRNA Technology. Molecular Therapy. 21(3). 570–579. 28 indexed citations
2.
Riabinska, Arina, Grit S. Herter-Sprie, Johannes Winkler, et al.. (2013). Therapeutic Targeting of a Robust Non-Oncogene Addiction to PRKDC in ATM -Defective Tumors. Science Translational Medicine. 5(189). 189ra78–189ra78. 77 indexed citations
3.
Viel, Thomas, Philipp Boehm‐Sturm, Parisa Monfared, et al.. (2013). Non-invasive imaging of glioma vessel size and densities in correlation with tumour cell proliferation by small animal PET and MRI. European Journal of Nuclear Medicine and Molecular Imaging. 40(10). 1595–1606. 13 indexed citations
4.
Viel, Thomas, Krishna M. Talasila, Parisa Monfared, et al.. (2012). Analysis of the Growth Dynamics of Angiogenesis-Dependent and -Independent Experimental Glioblastomas by Multimodal Small-Animal PET and MRI. Journal of Nuclear Medicine. 53(7). 1135–1145. 29 indexed citations
5.
Backes, Heiko, Thomas Viel, Markus P. Kummer, et al.. (2012). Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease. Neurobiology of Aging. 34(1). 351–354. 36 indexed citations
6.
Cerchia, Laura, et al.. (2012). Signal Transduction Alterations in Glioma: Implications for Diagnosis and Therapy. PubMed. 2012. 1–2. 4 indexed citations
7.
Ullrich, Roland T., Parisa Monfared, Thomas Viel, et al.. (2011). Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications. British Journal of Radiology. 84(special_issue_2). S179–S195. 3 indexed citations
8.
Waerzeggers, Yannic, Parisa Monfared, Slobodan Vukičević, et al.. (2011). Imaging Bone Morphogenetic Protein 7 Induced Cell Cycle Arrest in Experimental Gliomas. Neoplasia. 13(3). 276–IN22. 26 indexed citations
9.
Monfared, Parisa, Thomas Viel, Andreas Faust, et al.. (2011). Specific biomarkers of receptors, pathways of inhibition and targeted therapies: pre-clinical developments. British Journal of Radiology. 84(special_issue_2). S168–S178. 3 indexed citations
10.
Waerzeggers, Yannic, Parisa Monfared, Thomas Viel, Alexandra Winkeler, & Andreas H. Jacobs. (2010). Mouse models in neurological disorders: Applications of non-invasive imaging. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1802(10). 819–839. 37 indexed citations
11.
Waerzeggers, Yannic, Parisa Monfared, Thomas Viel, et al.. (2009). Methods to monitor gene therapy with molecular imaging. Methods. 48(2). 146–160. 47 indexed citations
12.
Waerzeggers, Yannic, Markus Klein, Hrvoje Miletić, et al.. (2008). Multimodal Imaging of Neural Progenitor Cell Fate in Rodents. Molecular Imaging. 7(2). 77–91. 40 indexed citations
13.
Winkeler, Alexandra, Yannic Waerzeggers, Alexander D. Klose, et al.. (2008). Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 35(S1). 107–113. 4 indexed citations
14.
Monfared, Parisa, Alexandra Winkeler, Markus Klein, et al.. (2008). Noninvasive Assessment of E2F-1–Mediated Transcriptional Regulation In vivo. Cancer Research. 68(14). 5932–5940. 7 indexed citations
15.
Winkeler, Alexandra, Miguel Sena‐Esteves, Leonie E. Paulis, et al.. (2007). Switching on the Lights for Gene Therapy. PLoS ONE. 2(6). e528–e528. 18 indexed citations
16.
Jacobs, Andreas H., Alexandra Winkeler, R. Hilker, et al.. (2003). PET-based molecular imaging in neuroscience. European Journal of Nuclear Medicine and Molecular Imaging. 30(7). 1051–1065. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026